Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Anderson, Sarah‐Jane
62  Ergebnisse:
Personensuche X
?
1

Comparative Efficacy and Safety of Fostemsavir in Heavily T..:

Anderson, Sarah-Jane ; van Doornewaard, Alexander ; Turner, Matthew...
Clinical Therapeutics.  44 (2022)  6 - p. 886-900 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of..:

Anderson, Sarah-Jane ; Murray, Miranda ; Cella, David...
The Patient - Patient-Centered Outcomes Research.  15 (2021)  1 - p. 131-143 , 2021
Link: https://doi.org/10.1007/..
 
?
3

Cost-effectiveness of the long-acting regimen cabotegravir ..:

Parker, Ben ; Ward, Tom ; Hayward, Olivia...
PLOS ONE.  16 (2021)  2 - p. e0245955 , 2021
Link: https://doi.org/10.1371/..
 
?
4

Cost-Effectiveness of Juluca (dolutegravir/rilpivirine) for..:

Anderson, Sarah-Jane ; Hsu, Chiung-Yuan ; Ou, Huang-Tz...
Value in Health Regional Issues.  24 (2021)  - p. 216-223 , 2021
Link: https://doi.org/10.1016/..
 
?
5

1018. Health Technology Assessment of New Long-Acting, Dire..:

Arthurs, Erin ; Parker, Ben ; Jacob, Ian...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S538-S539 , 2020
Link: https://doi.org/10.1093/..
 
?
6

The importance of local epidemic conditions in monitoring p..:

Anderson, Sarah‐Jane ; Garnett, Geoffrey P ; Enstone, Joanne.
Journal of the International AIDS Society.  21 (2018)  11 - p. , 2018
Link: https://doi.org/10.1002/..
 
?
7

Appraising the value of evidence generation activities: an ..:

Woods, Beth ; Rothery, Claire ; Anderson, Sarah-Jane...
BMJ Global Health.  3 (2018)  6 - p. e000488 , 2018
Link: https://doi.org/10.1136/..
 
?
8

Frontloading HIV financing maximizes the achievable impact ..:

Anderson, Sarah‐Jane ; Ghys, Peter D ; Ombam, Regina.
Journal of the International AIDS Society.  21 (2018)  3 - p. , 2018
Link: https://doi.org/10.1002/..
 
?
9

Spatial patterns of HIV prevalence and service use in East ..:

Schaefer, Robin ; Gregson, Simon ; Takaruza, Albert...
Journal of the International AIDS Society.  20 (2017)  1 - p. , 2017
Link: https://doi.org/10.7448/..
 
?
10

HIV prevention where it is needed most: comparison of strat..:

Anderson, Sarah‐Jane ; Ghys, Peter D ; Ombam, Regina.
Journal of the International AIDS Society.  20 (2017)  4 - p. , 2017
Link: https://doi.org/10.1002/..
 
?
11

PrEP as a feature in the optimal landscape of combination H..:

McGillen, Jessica B ; Anderson, Sarah‐Jane ; Hallett, Timothy B
Journal of the International AIDS Society.  19 (2016)  7S6 - p. , 2016
Link: https://doi.org/10.7448/..
 
?
12

Maximising HIV prevention by balancing the opportunities of..:

Smith, Jennifer A ; Anderson, Sarah-Jane ; Harris, Kate L...
The Lancet HIV.  3 (2016)  7 - p. e289-e296 , 2016
Link: https://doi.org/10.1016/..
 
?
13

How robust are the natural history parameters used in chlam..:

Davies, Bethan ; Anderson, Sarah-Jane ; Turner, Katy ME.
Theoretical Biology and Medical Modelling.  11 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
14

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of..:

Anderson, Sarah-Jane ; Murray, Miranda ; Cella, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739158/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

1018. Health Technology Assessment of New Long-Acting, Dire..:

Arthurs, Erin ; Parker, Ben ; Jacob, Ian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777051/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
1-15